MIRD pamphlet No. 21: a generalized schema for radiopharmaceutical dosimetry--standardization of nomenclature.
about
Hybrid Imaging for Patient-Specific Dosimetry in Radionuclide TherapyIntroduction to radiobiology of targeted radionuclide therapyFeasibility of Multiple Examinations Using (68)Ga-Labelled Collagelin Analogues: Organ Distribution in Rat for Extrapolation to Human Organ and Whole-Body Radiation Dosimetry.Updated anatomical data and mathematical models for embryo/fetus dosimetryEffective dose to adult patients from 338 radiopharmaceuticals estimated using ICRP biokinetic data, ICRP/ICRU computational reference phantoms and ICRP 2007 tissue weighting factors.Whole body MR-PET: a new internal dosimetry method for radiation transport calculation from biokinetic model data.Assessment of the Absorbed Dose in the Kidney of Nuclear Nephrology Paediatric Patients using ICRP Biokinetic Data and Monte Carlo Simulations with Mass-Scaled Paediatric Voxel Phantoms.Hybrid computational phantoms for medical dose reconstruction.Internal dosimetry estimates using voxelized reference phantoms for thyroid agents.Tetraspanin 8 (TSPAN 8) as a potential target for radio-immunotherapy of colorectal cancerDosimetry for radiopharmaceutical therapyDosimetric analysis of (123)I, (125)I and (131)I in thyroid follicle models.The Beginning and Development of the Theranostic Approach in Nuclear Medicine, as Exemplified by the Radionuclide Pair 86Y and 90Y.The potential and hurdles of targeted alpha therapy - clinical trials and beyond.Human biodistribution and radiation dosimetry of novel PET probes targeting the deoxyribonucleoside salvage pathwayDosimetry of 18F-labeled tyrosine kinase inhibitor SKI-249380, a dasatinib-tracer for PET imaging.Human biodistribution and radiation dosimetry of 82Rb.Radiation dosimetry of 82Rb in humans under pharmacologic stressTranscriptional response in normal mouse tissues after i.v. (211)At administration - response related to absorbed dose, dose rate, and timeDosimetry of [(177)Lu]-DO3A-VS-Cys(40)-Exendin-4 - impact on the feasibility of insulinoma internal radiotherapy.Biokinetics and dosimetry of commonly used radiopharmaceuticals in diagnostic nuclear medicine - a reviewTherapeutic application of CCK2R-targeting PP-F11: influence of particle range, activity and peptide amountTranscriptional Response in Mouse Thyroid Tissue after 211At Administration: Effects of Absorbed Dose, Initial Dose-Rate and Time after AdministrationPotential Biomarkers for Radiation-Induced Renal Toxicity following 177Lu-Octreotate Administration in MiceAn approach for balancing diagnostic image quality with cancer risk: application to pediatric diagnostic imaging of 99mTc-dimercaptosuccinic acid.Dose escalation and dosimetry of first-in-human α radioimmunotherapy with 212Pb-TCMC-trastuzumab.Initial Evaluation of [(18)F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate CancerRadioimmunotherapy of prostate cancer targeting human kallikrein-related peptidase 2.Radiation dosimetry of 18F-FDG PET/CT: incorporating exam-specific parameters in dose estimatesInvestigating the Effect of Ligand Amount and Injected Therapeutic Activity: A Simulation Study for 177Lu-Labeled PSMA-Targeting Peptides.A bone marrow toxicity model for ²²³Ra alpha-emitter radiopharmaceutical therapy.MIRD pamphlet No. 23: quantitative SPECT for patient-specific 3-dimensional dosimetry in internal radionuclide therapyComparison of internal dosimetry factors for three classes of adult computational phantoms with emphasis on I-131 in the thyroid.Transcriptional response of BALB/c mouse thyroids following in vivo astatine-211 exposure reveals distinct gene expression profiles.Circadian rhythm influences genome-wide transcriptional responses to (131)I in a tissue-specific manner in mice.Imaging, Biodistribution, and Dosimetry of Radionuclide-Labeled PD-L1 Antibody in an Immunocompetent Mouse Model of Breast Cancer.Hemopoietic response to low dose-rates of ionizing radiation shows stem cell tolerance and adaptation.S values for 131I based on the ICRP adult voxel phantoms.Application of (212)Pb for Targeted α-particle Therapy (TAT): Pre-clinical and Mechanistic Understanding through to Clinical Translation.Glucagon-like peptide-1 receptor imaging with [Lys40(Ahx-HYNIC- 99mTc/EDDA)NH2]-exendin-4 for the detection of insulinoma.
P2860
Q26768478-299CB10F-767E-44E4-8863-EA79D0B69BC0Q26852029-5612B479-2C9E-43CB-88E1-D2A7B49AFD51Q30379281-DF84DF39-96C8-4DD7-A710-DEAC4883A6B0Q30636949-73F39D39-A272-4626-A9D4-922C1C956EAEQ31011083-1687D7C6-A95C-4869-9A57-103BC3527BE6Q31011183-17B38A0A-6B08-4A98-9329-221A3EE9DB73Q31082910-53D4F214-3A7D-44E8-A643-A9A3C0E00E42Q33521035-309BC6AB-5F7F-427E-BCCD-9DF2C498A206Q33582591-23915779-3C1E-4333-9688-F9959BEF4E69Q33591800-5C9BA513-A844-46CC-A431-8902F020F76DQ33665116-FBC717D7-4CC6-4B90-B90C-7D537E2FA184Q33833023-10E1BB01-A453-4AB3-9705-E65A95329A88Q33851546-3F28728A-80DF-49B6-8CA5-89187FCC44E1Q34399879-001360EB-025A-4666-ACA9-6BECE37E2E13Q34648037-EB3719D6-3BF6-4C8C-9269-A7C8CA846285Q35040549-3FA08EC0-C0DD-45B4-9D4C-4462EFC26176Q35212024-CE0145F2-E0E3-4C8A-839A-8FD47B5AEA7AQ35212060-F1C360CC-333A-4D5F-9183-FB914AAE1051Q35261291-9159D0B3-B900-4EFF-A3A1-AE6762DC9C99Q35402008-7CD8873D-3BEA-4E86-BE7D-AF513CF56F65Q35556123-639C0033-8FA0-4A05-B061-4FEC18DE804CQ35675498-AC90703D-357B-4649-ACBE-09C37F7F988BQ35692449-22B533C6-9BA2-485F-8CC6-B22F81890EC3Q35750002-7AD31D29-D164-465F-9A90-98D91F93354FQ35791833-527D3F0A-D1BF-46C1-B019-AD52A81C9017Q35800092-724D2F02-74E0-46C5-8259-950610B225E8Q35938051-974ED8D5-A99F-41C7-9AF1-E74B450D71A1Q35959942-384C4036-78D5-47AD-8A97-7B1C0C77AF76Q36055989-F43DFEA3-A3DA-4B87-A519-E07720088D7FQ36128368-53C1F4A2-4FCF-440E-9B2E-EE80794E1D08Q36235572-66B1FF66-6434-48DB-B6BF-341681F32A9CQ36302205-D9867ABF-0464-47FF-8BF3-BBD6D81B2071Q36359352-79F0D670-902D-41EF-97C7-5C8752A40FE7Q36372946-2A3621FE-625D-4778-ACB4-81321254594AQ36373469-B53BA8B2-5CFB-429F-A394-6413BEC36DB9Q36471252-4F2E5332-254A-4B2E-A2A2-FA207E76027CQ36478176-63E4A1BF-E787-4FCA-9AEA-088349868A31Q36509422-BDD672D7-4456-4577-A2A5-22FBF89502B2Q36551498-8B36E791-D578-4C8D-976D-1875C9AFA89EQ36662850-26816997-2BD8-47CA-A974-B6E83B70F3CA
P2860
MIRD pamphlet No. 21: a generalized schema for radiopharmaceutical dosimetry--standardization of nomenclature.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
MIRD pamphlet No. 21: a genera ...... andardization of nomenclature.
@en
MIRD pamphlet No. 21: a genera ...... andardization of nomenclature.
@nl
type
label
MIRD pamphlet No. 21: a genera ...... andardization of nomenclature.
@en
MIRD pamphlet No. 21: a genera ...... andardization of nomenclature.
@nl
prefLabel
MIRD pamphlet No. 21: a genera ...... andardization of nomenclature.
@en
MIRD pamphlet No. 21: a genera ...... andardization of nomenclature.
@nl
P1476
MIRD pamphlet No. 21: a genera ...... andardization of nomenclature.
@en
P2093
Keith F Eckerman
Stephen R Thomas
P304
P356
10.2967/JNUMED.108.056036
P407
P577
2009-03-01T00:00:00Z